Cargando…
Uncovering the Pharmacological Mechanisms of Gexia-Zhuyu Formula (GXZY) in Treating Liver Cirrhosis by an Integrative Pharmacology Strategy
Liver cirrhosis (LC) is a fibrotic lesion of liver tissue caused by the repeated progression of chronic hepatitis. The traditional Chinese medicine Gexia-Zhuyu formula (GXZY) has a therapeutic effect on LC. However, its pharmacological mechanisms on LC remain elucidated. Here, we used the network ph...
Autores principales: | Cao, Xu, Liang, Yijun, Liu, Ruijia, Zao, Xiaobin, Zhang, Jiaying, Chen, Guang, Liu, Ruijie, Chen, Hening, He, Yannan, Zhang, Jiaxin, Ye, Yong’an |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8940433/ https://www.ncbi.nlm.nih.gov/pubmed/35330838 http://dx.doi.org/10.3389/fphar.2022.793888 |
Ejemplares similares
-
Exploring the mechanism of JiGuCao capsule formula on treating hepatitis B virus infection via network pharmacology analysis and in vivo/vitro experiment verification
por: Cao, Xu, et al.
Publicado: (2023) -
The mechanism of TiaoGanYiPi formula for treating chronic hepatitis B by network pharmacology and molecular docking verification
por: Cao, Xu, et al.
Publicado: (2021) -
Pharmacodynamic Evaluation of the Gexia Zhuyu Decoction in the Treatment of NAFLD and the Molecular Mechanism Underlying the TRPM4 Pathway Regulation
por: Zhao, Yao-Wei, et al.
Publicado: (2021) -
Network pharmacology and in vitro experiments-based strategy to investigate the mechanisms of KangXianYiAi formula for hepatitis B virus-related hepatocellular carcinoma
por: Cao, Xu, et al.
Publicado: (2022) -
Gexia-Zhuyu Decoction Attenuates Carbon Tetrachloride-Induced Liver Fibrosis in Mice Partly via Liver Angiogenesis Mediated by Myeloid Cells
por: Deng, Zhengming, et al.
Publicado: (2019)